Domains I and IV of Annexin A2 Affect the Formation and Integrity of In Vitro Capillary-Like Networks

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Raddum, Aase M ^a   Evensen, Lasse ^a   Hollås, Hanne ^a   Grindheim, Ann Kari ^a   Lorens, James B ^a   Vedeler, Anni ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 2; TYROSINE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VATALANIB;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL CONTACT; CELL MOTILITY; CELL STRUCTURE; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN TARGETING; SMOOTH MUSCLE FIBER;

ANIMALS; ANNEXIN A2; CATTLE; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROSCOPY, CONFOCAL; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; S100 PROTEINS;

EID: 84875510382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060281     Document Type: Article

References (81)

1. Gerke V, Moss SE, (2002) Annexins: from structure to function. Physiol Rev 82: 331-371.
2. Gerke V, Creutz CE, Moss SE, (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
3. Singh P, (2007) Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 252: 19-35.
4. Moss SE, Morgan RO, (2004) The annexins. Genome Biol 5: 219.
5. Rosengarth A, Luecke H, (2004) Annexin A2: Does It Induce Membrane Aggregation by a New Multimeric State of the Protein? Annexins 1: 129-136.
6. Grieve AG, Moss SE, Hayes MJ, (2012) Annexin A2 at the interface of actin and membrane dynamics: a focus on its roles in endocytosis and cell polarization. Int J Cell Biol 2012: 852430.
7. Valapala M, Vishwanatha JK, (2011) Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. J Biol Chem 286: 30911-30925.
8. Kim J, Hajjar KA, (2002) Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 7: d341-348.
9. Swisher JF, Burton N, Bacot SM, Vogel SN, Feldman GM, (2010) Annexin A2 tetramer activates human and murine macrophages through TLR4. Blood 115: 549-558.
10. Tressler RJ, Updyke TV, Yeatman T, Nicolson GL, (1993) Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem 53: 265-276.
11. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, et al. (1999) Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340: 994-1004.
12. Raynal P, Pollard HB, (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197: 63-93.
13. Harder T, Kellner R, Parton RG, Gruenberg J, (1997) Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol Biol Cell 8: 533-545.
14. Rescher U, Gerke V, (2008) S100A10/p11: family, friends and functions. Pflugers Arch 455: 575-582.
15. Hajjar KA, Jacovina AT, Chacko J, (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269: 21191-21197.
16. Hayes MJ, Shao D, Bailly M, Moss SE, (2006) Regulation of actin dynamics by annexin 2. EMBO J 25: 1816-1826.
17. Filipenko NR, Waisman DM, (2001) The C terminus of annexin II mediates binding to F-actin. J Biol Chem 276: 5310-5315.
18. Heyraud S, Jaquinod M, Durmort C, Dambroise E, Concord E, et al. (2008) Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol Cell Biol 28: 1657-1668.
19. Vedeler A, Hollas H, (2000) Annexin II is associated with mRNAs which may constitute a distinct subpopulation. Biochem J 348 Pt 3: 565-572.
20. Shao C, Zhang F, Kemp MM, Linhardt RJ, Waisman DM, et al. (2006) Crystallographic analysis of calcium-dependent heparin binding to annexin A2. J Biol Chem 281: 31689-31695.
21. Kang HM, Choi KS, Kassam G, Fitzpatrick SL, Kwon M, et al. (1999) Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc Med 9: 92-102.
22. Gokhale NA, Abraham A, Digman MA, Gratton E, Cho W, (2005) Phosphoinositide specificity of and mechanism of lipid domain formation by annexin A2-p11 heterotetramer. J Biol Chem 280: 42831-42840.
23. Zobiack N, Rescher U, Laarmann S, Michgehl S, Schmidt MA, et al. (2002) Cell-surface attachment of pedestal-forming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J Cell Sci 115: 91-98.
24. Rescher U, Gerke V, (2004) Annexins--unique membrane binding proteins with diverse functions. J Cell Sci 117: 2631-2639.
25. Futter CE, White IJ, (2007) Annexins and endocytosis. Traffic 8: 951-958.
26. Dejana E, Orsenigo F, Lampugnani MG, (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122.
27. Carmeliet P, (2003) Angiogenesis in health and disease. Nat Med 9: 653-660.
28. Carmeliet P, (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
29. Evensen L, Micklem DR, Blois A, Berge SV, Aarsaether N, et al. (2009) Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 4: e5798.
30. Korff T, Kimmina S, Martiny-Baron G, Augustin HG, (2001) Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15: 447-457.
31. Jain RK, (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
32. Evensen L, Micklem DR, Link W, Lorens JB, (2010) A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery. Cytometry A 77: 41-51.
33. Evensen L, Link W, Lorens JB, (2010) Imaged-based high-throughput screening for anti-angiogenic drug discovery. Curr Pharm Des 16: 3958-3963.
34. Thomas S, Harding MA, Smith SC, Overdevest JB, Nitz MD, et al. (2012) CD24 is an effector of HIF-1-driven primary tumor growth and metastasis. Cancer Res 72: 5600-5612.
35. Ke Q, Costa M, (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480.
36. Huang B, Deora AB, He KL, Chen K, Sui G, et al. (2011) Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood 118: 2918-2929.
37. Loges S, Mazzone M, Hohensinner P, Carmeliet P, (2009) Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 15: 167-170.
38. Zhao S, Huang L, Wu J, Zhang Y, Pan D, et al. (2009) Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy. Mol Vis 15: 1231-1242.
39. Zhou S, Yi T, Liu R, Bian C, Qi X, et al. (2012) Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol Cell Proteomics 11M112 017988.
40. Lokman NA, Ween MP, Oehler MK, Ricciardelli C, (2011) The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4: 199-208.
41. Aukrust I, Evensen L, Hollas H, Berven F, Atkinson RA, et al. (2006) Engineering, biophysical characterisation and binding properties of a soluble mutant form of annexin A2 domain IV that adopts a partially folded conformation. J Mol Biol 363: 469-481.
42. Gerke V, Weber K, (1984) Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J 3: 227-233.
43. Chen MH, Sheng J, Hind G, Handa AK, Citovsky V, (2000) Interaction between the tobacco mosaic virus movement protein and host cell pectin methylesterases is required for viral cell-to-cell movement. EMBO J 19: 913-920.
44. Flood EC, Hajjar KA, (2011) The annexin A2 system and vascular homeostasis. Vascul Pharmacol 54: 59-67.
45. Hollas H, Aukrust I, Grimmer S, Strand E, Flatmark T, et al. (2006) Annexin A2 recognises a specific region in the 3'-UTR of its cognate messenger RNA. Biochim Biophys Acta 1763: 1325-1334.
46. Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, et al. (2002) PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 62: 4015-4022.
47. Roda O, Valero ML, Peiro S, Andreu D, Real FX, et al. (2003) New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association? J Biol Chem 278: 5702-5709.
48. Cordier-Ochsenbein F, Guerois R, Baleux F, Huynh-Dinh T, Lirsac PN, et al. (1998) Exploring the folding pathways of annexin I, a multidomain protein. I. non-native structures stabilize the partially folded state of the isolated domain 2 of annexin I. J Mol Biol 279: 1163-1175.
49. Jones PG, Moore GJ, Waisman DM, (1992) A nonapeptide to the putative F-actin binding site of annexin-II tetramer inhibits its calcium-dependent activation of actin filament bundling. J Biol Chem 267: 13993-13997.
50. Babiychuk EB, Monastyrskaya K, Burkhard FC, Wray S, Draeger A, (2002) Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts. FASEB J 16: 1177-1184.
51. Lamalice L, Le Boeuf F, Huot J, (2007) Endothelial cell migration during angiogenesis. Circ Res 100: 782-794.
52. Im E, Kazlauskas A, (2006) New insights regarding vessel regression. Cell Cycle 5: 2057-2059.
53. Aukrust I, Hollas H, Strand E, Evensen L, Trave G, et al. (2007) The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV. J Mol Biol 368: 1367-1378.
54. Xu K, Sacharidou A, Fu S, Chong DC, Skaug B, et al. (2011) Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 20: 526-539.
55. Arnoys EJ, Wang JL, (2007) Dual localization: proteins in extracellular and intracellular compartments. Acta Histochem 109: 89-110.
56. Ozorowski G, Ryan CM, Whitelegge JP, Luecke H, (2012) Withaferin A binds covalently to the N-terminal domain of annexin A2. Biol Chem 393: 1151-1163.
57. Emans N, Gorvel JP, Walter C, Gerke V, Kellner R, et al. (1993) Annexin II is a major component of fusogenic endosomal vesicles. J Cell Biol 120: 1357-1369.
58. Gruenberg J, Stenmark H, (2004) The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 5: 317-323.
59. Jost M, Zeuschner D, Seemann J, Weber K, Gerke V, (1997) Identification and characterization of a novel type of annexin-membrane interaction: Ca2+ is not required for the association of annexin II with early endosomes. J Cell Sci 110 (Pt 2): 221-228.
60. Vincent PA, Xiao K, Buckley KM, Kowalczyk AP, (2004) VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 286: C987-997.
61. Morel E, Gruenberg J, (2007) The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport. PLoS One 2: e1118.
62. Zheng L, Foley K, Huang L, Leubner A, Mo G, et al. (2011) Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 6: e19390.
63. Morel E, Gruenberg J, (2009) Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation. J Biol Chem 284: 1604-1611.
64. Hoelzle MK, Svitkina T, (2012) The cytoskeletal mechanisms of cell-cell junction formation in endothelial cells. Mol Biol Cell 23: 310-323.
65. Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, et al. (1998) VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 238: 324-334.
66. Hajjar KA, Menell JS, (1997) Annexin II: a novel mediator of cell surface plasmin generation. Ann N Y Acad Sci 811: 337-349.
67. Cesarman GM, Guevara CA, Hajjar KA, (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269: 21198-21203.
68. Valapala M, Thamake SI, Vishwanatha JK, (2011) A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. J Cell Sci 124: 1453-1464.
69. Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, et al. (2000) Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem 275: 33189-33192.
70. Das S, Shetty P, Valapala M, Dasgupta S, Gryczynski Z, et al. (2010) Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells. Biochemistry 49: 2216-2226.
71. de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM, et al. (2008) Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin Activation. Mol Cell Biol 28: 1029-1040.
72. Rescher U, Ludwig C, Konietzko V, Kharitonenkov A, Gerke V, (2008) Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J Cell Sci 121: 2177-2185.
73. Sharma M, Blackman MR, Sharma MC, (2012) Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model. Exp Mol Pathol 92: 175-184.
74. Sharma M, Ownbey RT, Sharma MC, (2010) Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol.
75. Lee IH, You JO, Ha KS, Bae DS, Suh PG, et al. (2004) AHNAK-mediated activation of phospholipase C-gamma1 through protein kinase C. J Biol Chem 279: 26645-26653.
76. Benaud C, Gentil BJ, Assard N, Court M, Garin J, et al. (2004) AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol 164: 133-144.
77. Kirshner J, Schumann D, Shively JE, (2003) CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis. J Biol Chem 278: 50338-50345.
78. Su SC, Maxwell SA, Bayless KJ, (2010) Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J Biol Chem 285: 40624-40634.
79. Vestweber D, (2008) VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232.
80. Yap AS, Crampton MS, Hardin J, (2007) Making and breaking contacts: the cellular biology of cadherin regulation. Curr Opin Cell Biol 19: 508-514.
81. Sarkar S, Kantara C, Singh P, (2012) Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2. Am J Physiol Gastrointest Liver Physiol 302: G712-722.